BBCMF (Lir Life Sciences) Other Stockholders Equity: $0.53 Mil (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Other Stockholders Equity?

Lir Life Sciences BBCMF -80.00% 15 Other Stockholders Equity is $0.53 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Lir Life Sciences's Other Stockholders Equity for the quarter that ended in Jan. 2026 was $0.53 Mil.

Lir Life Sciences's quarterly Other Stockholders Equity declined from Jul. 2025 ($0.00 Mil) to Oct. 2025 ($-0.00 Mil) but then increased from Oct. 2025 ($-0.00 Mil) to Jan. 2026 ($0.53 Mil).

Lir Life Sciences's annual Other Stockholders Equity stayed the same from . 20 ($0.00 Mil) to Apr. 2024 ($0.00 Mil) but then increased from Apr. 2024 ($0.00 Mil) to Apr. 2025 ($0.05 Mil).

Lir Life Sciences Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Other Stockholders Equity Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Other Stockholders Equity
0.00 0.05

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Other Stockholders Equity Get a 7-Day Free Trial 0.00 0.05 0.00 -0.00 0.53
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.53 Mil mean?
Lir Life Sciences (BBCMF) has a Other Stockholders Equity of $0.53 Mil as of Jan. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' Other Stockholders Equity too high?
Lir Life Sciences' current Other Stockholders Equity is $0.53 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Other Stockholders Equity compare to VRTX and REGN?
Lir Life Sciences' Other Stockholders Equity of $0.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Other Stockholders Equity is $0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Other Stockholders Equity of $0.53 Mil. The current Other Stockholders Equity is $0.53 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Other Stockholders Equity is $0.53 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price